JP2004537274A - 軟骨形成におけるマトリックス遺伝子発現 - Google Patents

軟骨形成におけるマトリックス遺伝子発現 Download PDF

Info

Publication number
JP2004537274A
JP2004537274A JP2002564954A JP2002564954A JP2004537274A JP 2004537274 A JP2004537274 A JP 2004537274A JP 2002564954 A JP2002564954 A JP 2002564954A JP 2002564954 A JP2002564954 A JP 2002564954A JP 2004537274 A JP2004537274 A JP 2004537274A
Authority
JP
Japan
Prior art keywords
sequence
polypeptide
seq
sequence shown
division
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002564954A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004537274A5 (https=
Inventor
ロウビン，レベッカ
ゴーシュ，ピーター
Original Assignee
コンドロジェネシス ピーティーワイ リミテッド
ザ ユニバーシティー オブ シドニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by コンドロジェネシス ピーティーワイ リミテッド, ザ ユニバーシティー オブ シドニー filed Critical コンドロジェネシス ピーティーワイ リミテッド
Publication of JP2004537274A publication Critical patent/JP2004537274A/ja
Publication of JP2004537274A5 publication Critical patent/JP2004537274A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2002564954A 2001-02-15 2002-02-15 軟骨形成におけるマトリックス遺伝子発現 Pending JP2004537274A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPR3116A AUPR311601A0 (en) 2001-02-15 2001-02-15 Matrix gene expression in chondrogenesis
PCT/AU2002/000163 WO2002064625A1 (en) 2001-02-15 2002-02-15 Matrix gene expression in chondrogenesis

Publications (2)

Publication Number Publication Date
JP2004537274A true JP2004537274A (ja) 2004-12-16
JP2004537274A5 JP2004537274A5 (https=) 2006-01-05

Family

ID=3827137

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002564954A Pending JP2004537274A (ja) 2001-02-15 2002-02-15 軟骨形成におけるマトリックス遺伝子発現

Country Status (8)

Country Link
US (1) US20040157329A1 (https=)
EP (1) EP1370579A4 (https=)
JP (1) JP2004537274A (https=)
AU (1) AUPR311601A0 (https=)
CA (1) CA2440743A1 (https=)
NO (1) NO20033624L (https=)
NZ (1) NZ528202A (https=)
WO (1) WO2002064625A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190084070A (ko) * 2016-11-13 2019-07-15 이매진 파마 당뇨병, 고혈압 및 고콜레스테롤혈증을 치료하기 위한 조성물 및 방법
JP2021510157A (ja) * 2018-01-09 2021-04-15 イマジン ファーマ、エルエルシー 内皮細胞機能障害を調節するためのｒｐｓ２ペプチドの使用

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004026944D1 (de) * 2003-03-28 2010-06-10 Fujifilm Mfg Europe Bv RGD-angereicherte gelatineähnliche Proteine zur Verhinderung der Blutplättchenaggregation
US7318925B2 (en) * 2003-08-08 2008-01-15 Amgen Fremont, Inc. Methods of use for antibodies against parathyroid hormone
CN1838968A (zh) 2003-08-08 2006-09-27 艾伯吉尼斯公司 针对甲状旁腺激素(pth)之抗体和其用途
WO2005106495A1 (en) * 2004-05-04 2005-11-10 Pharmacia & Upjohn Company Llc Procollagen ii biomarkers and methods
US20080082170A1 (en) * 2006-09-29 2008-04-03 Peterman Marc M Apparatus and methods for surgical repair
ES2678211T3 (es) 2012-03-27 2018-08-09 Ventana Medical Systems, Inc. Conjugados de señalización y procedimientos de uso
WO2014093836A1 (en) * 2012-12-13 2014-06-19 University Of Georgia Research Foundation, Inc. Ossification-inducing composition and methods of use thereof
CN113096736B (zh) * 2021-03-26 2023-10-31 北京源生康泰基因科技有限公司 一种基于纳米孔测序的病毒实时自动分析方法及系统
CN113201487A (zh) * 2021-07-06 2021-08-03 广东先康达生物科技有限公司 成软骨细胞培养基及成软骨细胞的培养方法
CN113563458B (zh) * 2021-07-19 2023-07-21 嘉兴恒杰生物制药股份有限公司 一种非变性ii型胶原蛋白的制备方法
JP2024532985A (ja) * 2021-09-22 2024-09-12 イマジン ファーマ、エルエルシー １型糖尿病患者膵臓組織からインスリンおよびグルカゴン分泌細胞を増殖させるための組成物および方法およびその治療的使用
CN119504941B (zh) * 2024-12-03 2026-01-13 中国海洋大学 一种富含海洋肽钙螯合物的骨健康压片糖果及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5080891A (en) * 1987-08-03 1992-01-14 Ddi Pharmaceuticals, Inc. Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
US6159464A (en) * 1990-12-20 2000-12-12 University Of Pittsburgh Of The Commonwealth System Of Higher Education Viral vectors to inhibit leukocyte infiltration or cartilage degradation of joints
JP2001512013A (ja) * 1997-08-01 2001-08-21 ジェンセット 前立腺に発現される分泌タンパク質の５’ｅｓｔ
US20030144475A1 (en) * 1999-12-06 2003-07-31 Seishi Kato Human protein and cdna

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190084070A (ko) * 2016-11-13 2019-07-15 이매진 파마 당뇨병, 고혈압 및 고콜레스테롤혈증을 치료하기 위한 조성물 및 방법
JP2020502056A (ja) * 2016-11-13 2020-01-23 イマジン ファーマ 糖尿病、高血圧および高コレステロール血症を治療するための組成物および方法
KR102497242B1 (ko) 2016-11-13 2023-02-09 이매진 파마 당뇨병, 고혈압 및 고콜레스테롤혈증을 치료하기 위한 조성물 및 방법
JP2023071670A (ja) * 2016-11-13 2023-05-23 イマジン ファーマ、エルエルシー 糖尿病、高血圧および高コレステロール血症を治療するための組成物および方法
JP7711967B2 (ja) 2016-11-13 2025-07-23 イマジン ファーマ、エルエルシー 糖尿病、高血圧および高コレステロール血症を治療するための組成物および方法
JP2021510157A (ja) * 2018-01-09 2021-04-15 イマジン ファーマ、エルエルシー 内皮細胞機能障害を調節するためのｒｐｓ２ペプチドの使用

Also Published As

Publication number Publication date
AUPR311601A0 (en) 2001-03-08
EP1370579A4 (en) 2005-05-11
EP1370579A1 (en) 2003-12-17
WO2002064625A1 (en) 2002-08-22
NO20033624L (no) 2003-10-10
US20040157329A1 (en) 2004-08-12
NZ528202A (en) 2005-09-30
CA2440743A1 (en) 2002-08-22
NO20033624D0 (no) 2003-08-14

Similar Documents

Publication Publication Date Title
DE69513149T2 (de) Verfahren und Zusammensetzungen für die Stimulierung von Knochenzellen
Nakayama et al. A novel chordin-like BMP inhibitor, CHL2, expressed preferentially in chondrocytes of developing cartilage and osteoarthritic joint cartilage
US7563596B2 (en) Method of modulating tissue growth using Frzb protein
Lutz et al. Bone regeneration after topical BMP‐2‐gene delivery in circumferential peri‐implant bone defects
JP2004537274A (ja) 軟骨形成におけるマトリックス遺伝子発現
JP2006051032A (ja) 分泌及び膜貫通ポリペプチドとそれをコードする核酸
WO2002046364A2 (en) Genes associated with mechanical stress, expression products therefrom, and uses thereof
JP3982995B2 (ja) 形態形成タンパク質を含むＴＧＦ−βスーパーファミリー変異体メンバー
JP5905446B2 (ja) Ｂｍｐ−４ペプチドおよび使用方法
Gamradt et al. Tracking expression of virally mediated BMP-2 in gene therapy for bone repair
Harrington et al. Chondrocyte terminal differentiation, apoptosis, and type X collagen expression are downregulated by parathyroid hormone
Barling et al. Expression of PTHrP and the PTH/PTHrP receptor in growing red deer antler
WO2002042487A2 (en) Compositions, methods and kits relating to remodelin
US20030228292A1 (en) Methods of inducing or enhancing connective tissue repair
CA2161979A1 (en) Cloning, expression and uses of dorsalin-1
US7049291B2 (en) Isolation and method of using tissue growth-inducing Frzb protein
Zhu et al. Emerging role of hypertrophic chondrocytes in tissue regeneration and fracture healing: a narrative review
AU2002233029A1 (en) Matrix gene expression in chondrogenesis
US7259253B2 (en) Genes associated with mechanical stress, expression products therefrom, and uses thereof
WO2003000724A2 (en) Polynucleotide sequences and vectors useful for the prevention or treatment of bone- or cartilage-related disorders
JP2024512305A (ja) 破骨細胞生成の新規制御因子としてのＬａタンパク質
US20020022026A1 (en) Genes associated with mechanical stress, expression products therefrom, and uses thereof
Aarts Nuclear targeting of parathyroid hormone-related protein and apoptosis
Green Identification of genes expressed in epiphyseal cartilage during endochondral bone formation
Brown MSX-2, calcitriol and the control of differentiation in adult human bone-derived cells

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050215

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050215

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050303

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050304

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20071106

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080408